Location:
UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT
Attorneys:
For Plaintiff-Appellant: DAVIDSON NIX ET AL. John S. Hodge 401 Market St. Ste. 700 Shreveport LA 71101-1657 (318-424-4342).
FOR TEXACO: CAFFERY OUBRE ET AL. Patrick T. Caffery Charles C. Garrison P.O. Drawer 12410 New Iberia LA 70562-2410 (318-364-1816) 420 Iberia St. (70560). Charlene Suzanne Dittmer Texaco Inc. Legal Dept. P.O. Box 60252 NOLA 60160 400 Poydras St. (595-1786). FOR LABORATORY: ALLEN GOOCH BOURGEOIS ET AL. Joel E. Gooch Nora M. Stelly P.O. Drawer 3768 Lafayette LA 70502-3768 (318-233-5056) 1015 St. John St. (70501-6767). KULLMAN INMAN ET AL. Charles H. Hollis Thomas P. Hubert 1100 Poydras St. Ste. 1600 NOLA 71063 (524-4162) P.O. Box 60118 (70160) not involved w/case - letter coming. FOR CONSOLIDATED: WARD & CLESI Lynn H. Frank Joseph R. Ward Jr. 639 Loyola Ave. Ste. 2100 NOLA 70113-3125 (561-0661). FOR AMERICAN DRUG: ANDREW DAVIS LEGG ET AL. Don G. Holladay Laura B. Hood 500 West Main Oklahoma OK 73102 (405-272-9241).
Court:
Before REAVLEY HIGGINBOTHAM and DeMOSS Circuit Court.
Author:
The Hon. Justice Higginbotham
We deal with the applicability of the Fair Credit Reporting Act 15 U.S.C. SEC. 1681 et seq. to workplace drug tests. We find that the FCRA may apply to drug tests in some circumstances but that the tests in this case are excluded from coverage under the "transactions and experiences" exclusion. 15 U.S.C. SEC. 1681a(d). Accordingly we affirm the judgment of the district court.
I.
David Hodge was employed by Texaco as an oil field pumper. Texaco tests its employees for drug use as part of evaluating its employees' "fitness for duty." Mobile Health Services ("MHS) collected urine samples from Texaco employees at the employees' job sites. On November 1 1988 MHS conducted an unannounced examination of employees at Hodge's jobsite. After Hodge failed an initial screening test involving the ability to track a moving point of light with his eyes MHS required him to provide a urine sample.
The sample was sent to Laboratory Specialists Inc. ("LSI") a laboratory that performs urine testing for Texaco. LSI reported that the Hodge sample tested positive for tetrahydrocannabinol evidence of marijuana use. Upon receiving LSI's report Texaco suspended Hodge without pay and began termination proceedings.
Hodge's father contacted Gerald Rome a Texaco executive vice president and asked him to investigate his son's pending termination. At Rome's request another Texaco executive instructed the New Orleans office to have LSI send a portion of Hodge's urine sample to Dr. Forest Tennant MD. a drug rehabilitation Counselor who worked with Texaco in developing its drug policies. Dr. Tennant sent the sample to American Biotest Laboratory Inc. and then reported to Texaco that the test was indeed positive. Texaco terminated Hodge for violating Texaco's substance abuse policy.
Hodge filed this action against LSI and Tennant contending that LSI and Tennant were "consumer reporting agencies" that violated the FCRA by failing to use reasonable procedures to guarantee maximum possible accuracy in their "consumer reports. Hodge also contended that Texaco violated the FCRA by failing to disclose the name and address of the drug testing laboratories when it terminated him.
Hodge brought this action against Texaco U.S.A. Laboratory Specialists Inc. Consolidated American Insurance Co. American Drug Screens Inc. and Dr. Forest Tennant alleging violations of the Fair Credit Reporting Act and pendent state-law claims.
The defendants filed a 12(b)(6) motion to dismiss contending that FCRA did not apply to urinalysis reports. The district court denied the motion. Hodge and the defendants moved for summary judgment on the question of FCRA coverage. The court granted the defendants' motion reasoning that the FCRA did not apply to the drug-screening reports in this case because these reports were not "consumer reports" within the meaning of FCRA. Hodge v. Texaco U.S.A. 764 F. Supp. 424 (W.D. La. 1991). Hodge appeals from this order of summary judgment.
II.
Hodge contends that urinalysis reports are "consumer reports" under FCRA when they are used to determine whether an employee should be fired. Under the FCRA "consumer reporting agencies" must follow certain procedures when releasing "consumer reports. A "consumer report" is defined as:
any written oral or other communication of any information by a consumer reporting agency bearing on a consumer's credit worthiness credit standing credit capacity character general reputation personal characteristics or mode of living which is used or expected to be used for the purpose of serving as a factor in establishing the consumer's eligibility for (2) employment purposes 15 U.S.C. SEC. 1681a(d)
Workplace drug tests such as those performed by LSI and Tennant fall within the plain language of this statute. The reports of the results of these drug tests are communications bearing on Hodge's personal characteristics which were used to determine his eligibility for employment.
Defendants argue that despite the statute's plain language urinalysis tests fall outside the general purposes of the FCRA which is the evaluation of individuals' creditworthiness. By its own terms however FCRA applies not only to credit reports but also to reports of consumers' employment eligibility. Comeau v. Brown & Williamson Tobacco Co. 915 F.2d 1264 (9th Cir. 1990). In Peller v. Retail Credit Co. 359 F. Supp. 1235 (N.D. Ga. 1973) Court found that lie detector tests revealing a plaintiffs' prior use of marijuana could be "consumer reports" if released to prospective employers by a retail credit company. The Federal Trade Commission the agency charged with enforcing its provisions has interpreted FCRA to apply to State Motor Vehicle Department records employment agencies' reports and even university career and placement offices' mailings of reference letters. We find no basis in the statutory language or the legislative history to conclude that medical-type reports were meant to be excluded from its coverage.
Admittedly the extension of FCRA to drug-screening reports case seems far from the original purposes behind the Act. However Congress has enacted this statutory language which covers a broad range of conduct by its very terms. We cannot depart from the plain language of this statute on the basis that Congress must not have meant what it said. Accordingly we conclude that workplace drug test reports are not categorically excluded from coverage under FCRA.
III.
Determining the general inclusion of drug tests within the definition of consumer reports does not end our inquiry into the applicability of the FCRA because the statute also excludes some transactions from coverage. Defendants assert that the report from LSI to Texaco falls within the scope of SEC.1681a(d)(A) which excludes from coverage "any report containing information solely as to transactions or experiences between the consumer and the person making the report." We agree.
The "transactions and experiences" provision exempts from coverage any report based on the reporter's first-hand experience of the subject. Therefore a retailing firm's disclosure of its own ledger experience with a customer Porter v. Talbot Perkins Children's Services 355 F. Supp. 174 177 (S.D.N.Y. 1973)) (quoting F.T.C.'s consumer credit guide) or a bank's report of its own experience with its customers Smith v. First National Bank 837 F.2d 1575 1579-80 (11th Cir. 1988) would not constitute a consumer report." The F.T.C.'s interpretative regulations state that as long as the report is not "based on information from an outside source " but rather is based solely on the reporter's own first-hand investigations of the subject the report will fall within the "transactions and experiences" exception. 16 C.F.R. Appendix Part 600 at 344 (1991).
LSI asserts that its report consists of its first-hand experience in performing the tests on the urine sample not on information gathered from outside sources. Hodge contends that LSI's urinalysis report does not fall within SEC. 1681a(d)(A)'s exclusion of first-hand reports for two reasons. First Hodge argues that because LSI relied on MHS's initial collection and delivery of the urine sample their analysis does not constitute a report of their own "first-hand experience." Second Hodge argues that LSI cannot have had first-hand experience with Hodge within the meaning of FCRA because it had no "trade experience" with Hodge as for instance Hodge's employer insurer or creditor. We reject both of Hodge's arguments and conclude that LSI's report to Texaco was based upon its transactions with Hodge within the meaning of the "transactions and experiences" exclusion.
Hodge's argument that LSI's experience with him was not "first-hand " because LSI did not itself collect the urine sample reads the "transactions and experiences" exclusion too narrowly. MHS's collection of the urine sample was a mechanical preliminary task. LSI did not rely on any information from MHS to produce its report that the urine sample labeled as Hodge's had tested positive for marijuana use. LSI merely reported the results of its scientific testing of the urine sample that Hodge provided them. Their report was based upon their experiences in testing the sample not upon any outside information.
Of course the accuracy of the reports will depend on whether LSI actually obtained Hodge's urine sample and not someone else's urine for their tests. This information was obtained however not from any independent experience by MHS but from forms filled out and signed by Hodge himself. The mere transmittal of the forms and the urine through MHS's custody procedures does not change the basic nature of LSI's analysis any more than the use of the mails to receive information about a customer would break the chain of "first-hand experience."
Hodge's second argument asserts that unless the reporter has a personal business transaction ("trade experience") with the subject of the report then the report cannot fall within the "transactions and experiences' exception. This construction of SEC. 1681a (d)(A) requires a strained reading of the statutory provisions and would lead to untenable results. See Peller v. Retail Credit Co. 359 F. Supp. 1235 (N.D. Ga. 1973). The "transactions and experiences" exception uses broad language in the same way as the rest of the definition of a consumer report does so. Neither one contains a limitation to trade experience. It would be incongruous to read such a limitation into the exclusion provision while reading the main part of the definition broadly enough to sweep in this kind of drug testing. Hodge cannot have it both ways. Thus we conclude that LSI's report to Texaco was not a consumer report.
IV.
Tennant's report to Texaco presents a more difficult case than LSI because Tennant's report contains some second-hand information. *fn1 Tennant sent Dodge's urine specimen to American Biotest Laboratory for testing and reported ABL's test results along with his own test results. Tennant was therefore not squarely governed by the exclusion under SEC. 1681a(d)(A) which requires that excluded reports contain "solely" information about "transactions or experiences between the consumer and the person making the report."
It is difficult to determine from the record the district court's basis for dismissing the claim against Tennant sua sponte. We conclude however that dismissal of the claim against Tennant is appropriate for reasons not fully addressed below. The record is completely devoid of evidence that Tennant meets the basic requirement for coverage under the FCRA that he be a "consumer reporting agency." Because we conclude that Dodge cannot demonstrate the existence of this element of his FCRA claim we affirm the dismissal of his claim.
The term "consumer reporting agency" is defined in the FCRA as "any person which for monetary fees dues or on a cooperative nonprofit basis regularly engages in whole or in part in the practice of assembling or evaluating consumer credit information or other information on consumers for the purpose of furnishing consumer reports. 15 U.S.C. SEC.1681a (emphasis added). Dr. Tennant is a drug rehabilitation Counselor who has worked with Texaco programs in various states. The undisputed record evidence demonstrates that his involvement with Hodge's drug retesting was solely a one-time referral because he happened to be working with Texaco Louisiana at the time a retest was requested. He was asked about a lab to use for the retest and recommended ABL. Because of logistical problems he acted as a go-between for Texaco and ABL.
Hodge has come forward with no evidence disputing this basic scenario and has not demonstrated that Tennant regularly engages in the collection of information about consumers. The requirement that a consumer reporting agency engage regularly in the collection of information was obviously intended to protect individuals like Dr. Tennant who engage in activities that might fall within the definition of the FCRA on a casual one-time basis. Thus we conclude that Hodge's claim against Tennant was properly dismissed. Although Tennant has not raised this argument in a motion for summary judgment we grant judgment for Tennant nonetheless for the sake of judicial economy because it is clear that Hodge's claim cannot succeed.
The judgment of the district court is AFFIRMED.
Concurring: The Hon. Justice DeMoss
I concur in the affirmance of the district court's judgment solely for the reasons set forth in Parts III and IV of the panel opinion. These reasons seem completely sufficient and adequate for our decision and render unnecessary the conclusion in Part II of the Panel opinion with which I disagree.
Notes:
*fn1 We note that although it does not change our analysis under the FCRA it is somewhat ironic that Dodge seeks recovery under the FCRA on the basis of additional testing which was done only at the behest of Dodge's father a long-time Texaco employee.